Literature DB >> 9821296

Gentamicin resistance in clinical strains of Enterobacteriaceae associated with reduced gentamicin uptake.

K Adwan1, N Abu-Hasan.   

Abstract

Seven strains of Enterobacteriaceae resistant to gentamicin obtained as representatives of the predominant resistance profiles in the clinical laboratories of Rafeidia and Al-Watani Hospitals in Nablus (Palestine) were included. Five strains showed a broad aminoglycoside resistance profile but contained no evidence of gentamicin acetylation, adenylation, or phosphorylation. Gentamicin uptake in two tested strains was significantly reduced, compared to that of gentamicin-sensitive E. coli (MIC, 0.5 microgram/mL). These strains are likely resistant due to a relative reduction of the amount of gentamicin and other aminoglycosides entering the bacterial cell. Two strains showed evidence of adenyltransferase ANT(2")-I activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821296     DOI: 10.1007/bf02818588

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  8 in total

1.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis.

Authors:  S Takahashi; Y Nagano
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

Review 4.  Mechanisms of resistance to aminoglycosides in clinical isolates.

Authors:  K Shannon; I Phillips
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

5.  Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.

Authors:  W F McNeill; J F John; J A Twitty
Journal:  Am J Clin Pathol       Date:  1984-06       Impact factor: 2.493

6.  Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Authors:  K Hirai; H Aoyama; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

7.  Transferable amikacin resistance in gram-negative bacterial isolates.

Authors:  J Kallová; T Macicková; A Majtánová; A Aghová; D Adam; M Kettner
Journal:  Chemotherapy       Date:  1995 May-Jun       Impact factor: 2.544

8.  Hydroxystreptomycin production and resistance in Streptomyces glaucescens.

Authors:  H Ono; R Crameri; G Hintermann; R Hütter
Journal:  J Gen Microbiol       Date:  1983-02
  8 in total
  6 in total

1.  In vitro antimicrobial activity of ZnO based glass-ceramics against pathogenic bacteria.

Authors:  Madeeha Riaz; Rehana Zia; Farhat Saleemi; Hafeez Ikram; Farooq Bashir
Journal:  J Mater Sci Mater Med       Date:  2015-10-27       Impact factor: 3.896

2.  Creating Robust Antimicrobial Materials with Sticky Tyrocidines.

Authors:  Wilma van Rensburg; Marina Rautenbach
Journal:  Antibiotics (Basel)       Date:  2022-01-28

3.  Potential in vitro antimicrobial efficacy of Holigarna arnottiana (Hook F).

Authors:  Aseer Manilal; Akbar Idhayadhulla
Journal:  Asian Pac J Trop Biomed       Date:  2014-01

4.  Selective medium for primary isolation of members of the tribe Proteeae.

Authors:  E Urbanová
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.629

5.  In vitro antibacterial and time-kill assessment of crude methanolic stem bark extract of Acacia mearnsii de wild against bacteria in shigellosis.

Authors:  Olufunmiso Olusola Olajuyigbe; Anthony Jide Afolayan
Journal:  Molecules       Date:  2012-02-21       Impact factor: 4.411

6.  Mosquito larvicidal and antimicrobial activity of protein of Solanum villosum leaves.

Authors:  Nandita Chowdhury; Subrata Laskar; Goutam Chandra
Journal:  BMC Complement Altern Med       Date:  2008-12-06       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.